BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 27664860)

  • 1. Tumor treating fields: a novel treatment modality and its use in brain tumors.
    Hottinger AF; Pacheco P; Stupp R
    Neuro Oncol; 2016 Oct; 18(10):1338-49. PubMed ID: 27664860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
    Stupp R; Taillibert S; Kanner AA; Kesari S; Steinberg DM; Toms SA; Taylor LP; Lieberman F; Silvani A; Fink KL; Barnett GH; Zhu JJ; Henson JW; Engelhard HH; Chen TC; Tran DD; Sroubek J; Tran ND; Hottinger AF; Landolfi J; Desai R; Caroli M; Kew Y; Honnorat J; Idbaih A; Kirson ED; Weinberg U; Palti Y; Hegi ME; Ram Z
    JAMA; 2015 Dec; 314(23):2535-43. PubMed ID: 26670971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the Role of Tumor-treating Fields in Newly Diagnosed Glioblastoma?
    Ornelas AS; Porter AB; Sharma A; Knox MG; Marks LA; Wingerchuk DM; O'Carroll CB
    Neurologist; 2019 Mar; 24(2):71-73. PubMed ID: 30817495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
    Stupp R; Taillibert S; Kanner A; Read W; Steinberg D; Lhermitte B; Toms S; Idbaih A; Ahluwalia MS; Fink K; Di Meco F; Lieberman F; Zhu JJ; Stragliotto G; Tran D; Brem S; Hottinger A; Kirson ED; Lavy-Shahaf G; Weinberg U; Kim CY; Paek SH; Nicholas G; Bruna J; Hirte H; Weller M; Palti Y; Hegi ME; Ram Z
    JAMA; 2017 Dec; 318(23):2306-2316. PubMed ID: 29260225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.
    Zhu P; Zhu JJ
    Chin Clin Oncol; 2017 Aug; 6(4):41. PubMed ID: 28841803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial.
    Kim CY; Paek SH; Nam DH; Chang JH; Hong YK; Kim JH; Kim OL; Kim SH
    J Neurooncol; 2020 Feb; 146(3):399-406. PubMed ID: 32020470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.
    Mittal S; Klinger NV; Michelhaugh SK; Barger GR; Pannullo SC; Juhász C
    J Neurosurg; 2018 Feb; 128(2):414-421. PubMed ID: 28298023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor treating fields: concept, evidence and future.
    Pless M; Weinberg U
    Expert Opin Investig Drugs; 2011 Aug; 20(8):1099-106. PubMed ID: 21548832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system.
    Turner SG; Gergel T; Wu H; Lacroix M; Toms SA
    World J Surg Oncol; 2014 May; 12():162. PubMed ID: 24884522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists.
    Burri SH; Gondi V; Brown PD; Mehta MP
    Am J Clin Oncol; 2018 Feb; 41(2):191-196. PubMed ID: 28832384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.
    Taphoorn MJB; Dirven L; Kanner AA; Lavy-Shahaf G; Weinberg U; Taillibert S; Toms SA; Honnorat J; Chen TC; Sroubek J; David C; Idbaih A; Easaw JC; Kim CY; Bruna J; Hottinger AF; Kew Y; Roth P; Desai R; Villano JL; Kirson ED; Ram Z; Stupp R
    JAMA Oncol; 2018 Apr; 4(4):495-504. PubMed ID: 29392280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour treating fields therapy for glioblastoma: current advances and future directions.
    Rominiyi O; Vanderlinden A; Clenton SJ; Bridgewater C; Al-Tamimi Y; Collis SJ
    Br J Cancer; 2021 Feb; 124(4):697-709. PubMed ID: 33144698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Treating Fields: Nursing Implications for an Emerging Technology
.
    Chang A
    Clin J Oncol Nurs; 2017 Jun; 21(3):302-304. PubMed ID: 28524900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Treating Glioblastoma With Tumor-Treating Fields Therapy.
    Saria MG; Kesari S
    Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S9-S13. PubMed ID: 27668388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes.
    Rehman AA; Elmore KB; Mattei TA
    Neurosurg Focus; 2015 Mar; 38(3):E14. PubMed ID: 25727223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial.
    Guberina N; Pöttgen C; Kebir S; Lazaridis L; Scharmberg C; Lübcke W; Niessen M; Guberina M; Scheffler B; Jendrossek V; Jabbarli R; Pierscianek D; Sure U; Schmidt T; Oster C; Hau P; Grosu AL; Stuschke M; Glas M; Nour Y; Lüdemann L
    Radiat Oncol; 2020 Apr; 15(1):83. PubMed ID: 32307022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling.
    Wenger C; Miranda PC; Salvador R; Thielscher A; Bomzon Z; Giladi M; Mrugala MM; Korshoej AR
    IEEE Rev Biomed Eng; 2018; 11():195-207. PubMed ID: 29993870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor treating fields: a new frontier in cancer therapy.
    Davies AM; Weinberg U; Palti Y
    Ann N Y Acad Sci; 2013 Jul; 1291():86-95. PubMed ID: 23659608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China.
    Xiang Y; Chen Y; Xu Z; Zhou S; Qin Z; Chen L; Xiao D; Liu S
    J Neurooncol; 2024 Jun; 168(2):259-267. PubMed ID: 38563851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations.
    Lok E; Swanson KD; Wong ET
    Expert Rev Med Devices; 2015; 12(6):717-26. PubMed ID: 26513694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.